KNC Laboratories Co., Ltd. (FRA:7LW)

Germany · Delayed Price · Currency is EUR

6.24

+0.26 (4.35%)

At close: Jul 31, 2026

12.07% (1Y)

Market Cap	53.16M +7.2%
Revenue (ttm)	36.04M +21.0%
Net Income	3.06M
EPS	0.51
Shares Out	n/a
PE Ratio	17.40
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	6.21
Previous Close	5.98
Day's Range	6.20 - 6.24
52-Week Range	5.46 - 6.54
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About KNC Laboratories

KNC Laboratories Co., Ltd. engages in the research, development, and production solutions of organic chemicals in Japan. The company offers its products for use in the pharmaceutical, electronic-chemical, agrochemical, energy, and environment fields. It also provides support services for drugs and functional chemicals. The company was incorporated in 1985 and is headquartered in Kobe, Japan. [Read more]

Industry Chemicals and Allied Products

Founded 1985

Employees 219

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 7LW

Financial Performance

In fiscal year 2016, KNC Laboratories's revenue was 4.61 billion, an increase of 20.99% compared to the previous year's 3.81 billion. Earnings were 391.00 million, an increase of 114.81%.

Financial numbers in JPY Financial Statements